Search form

Home
LoginSubscribe
  • Home
  • Country Intelligence
  • Industry Directory
  • Offsets / IC
  • Tenders
    • Haiti(0/week)
    • Guyana(0/week)
    • Honduras(0/week)
    • Jamaica(0/week)
    • Netherlands Antilles(0/week)
    • View all (0/week)
  • News
    • United States(1155/week)
    • Manufacturing(555/week)
    • Technology(1085/week)
    • Energy(397/week)
    • Other Manufacturing(315/week)
  • Events
  • About us
    • Who we are
    • Our People
    • Partners
    • Contact us
  • LinkedIn
  • Login
  • Twitter
  • Register
  • Home
  • News

Human papillomavirus infection

Jun 18, 2020
Worldwide Human Papillomavirus (HPV) Vaccines Overview 2020 - Pipeline & Marketed Vaccines, Regulatory Events, Clinical Trial Landscape, Future Trends, KOL Insights, Unmet Needs, Sales (2015-2024)
Jun 18, 2020
Neauvia North America continues its commitment to Safety and Innovation in Aesthetics
Jun 17, 2020
ISA Pharmaceuticals Strengthens Strategic Immuno-Oncology Collaboration With Regeneron
Jun 16, 2020
U.S. Genital Warts Market Analysis, 2017-2030 - Epidemiology, Drugs, Therapies, Vaccines, Companies, Unmet Needs, Reimbursement
Jun 16, 2020
Support for cervical cancer screening using Pap and HPV testing together continues to grow among health care providers and women
May 12, 2020
INOVIO to Present at RBC Capital Markets Virtual Global Healthcare Conference
May 11, 2020
INOVIO Reports First Quarter 2020 Financial Results; Provides Business Update
Apr 20, 2020
Precigen Announces Clearance of IND to Initiate Phase I/II Study for First-in-Class PRGN-2009 AdenoVerse(TM) Immunotherapy to Treat HPV-positive (HPV+) Solid Tumors
Apr 15, 2020
INOVIO to Host its Annual Meeting of Stockholders in Virtual Format and at a New Time
Mar 30, 2020
INOVIO Interim Results of an Open-Label Phase 2 Trial of VGX-3100 Show Efficacy Against HPV-associated Vulvar Dysplasia
Mar 19, 2020
ISA Pharma Publishes Phase 2 Study Data in Major Peer-reviewed Journal
Mar 12, 2020
INOVIO Pharmaceuticals Reports 2019 Fourth Quarter and Year-End Financial Results
Mar 02, 2020
Inovio Pharmaceuticals to Report Fourth Quarter and Full Year 2019 Financial Results on March 12, 2020
Mar 02, 2020
Inovio Pharmaceuticals to Report Fourth Quarter and Full Year 2019 Financial Results on March 12, 2020
Feb 14, 2020
The global HPV testing market is expected to grow at a CAGR of over 12% during the period 2019-2025
Feb 13, 2020
2020-2025 Human Papillomavirus (HPV) Testing Industry Report - Roche, Qiagen, Hologic and Abbott are Dominating the Competition
Feb 12, 2020
The Global Human Papillomavirus (HPV) Testing Market to Reach Revenues of Over $1 Billion During the Period 2020 -2025 - Market Research by Arizton
Feb 10, 2020
Inovio Receives Authorization from the U.S. FDA To Begin Phase 1/2 Clinical Trial for INO-3107, a DNA Medicine To Treat a Rare Disease -- Recurrent Respiratory Papillomatosis (RRP)
Feb 07, 2020
Disease Analysis: Human Papillomavirus (HPV) Vaccines
Feb 03, 2020
Inovio Publishes Patient Benefit Results From A Pilot Clinical Study in Recurrent Respiratory Papillomatosis (RRP), A Rare Disease Caused by HPV Infections
  •  
  • Page 1
  • ››

Latest News

Jun 11, 2025

Sherritt Reports Shareholder Meeting Results, Board Appointments and Committee Updates

Jun 11, 2025

Voyager Announces Pricing of Initial Public Offering

Jun 11, 2025

H&P To Participate in J.P. Morgan 2025 Energy, Power and Renewables Conference

Jun 11, 2025

CACI President and CEO John Mengucci Named ‘Executive of the Year’ by ACG National Capital

Jun 11, 2025

Atlas Announces Timing of Second Quarter 2025 Earnings Release and Conference Call

Jun 11, 2025

Kaiser Aluminum Corporation Announces Appointment of Glenda J. Minor to its Board of Directors

Jun 11, 2025

The SEER Group Expands Northwest Presence With Acquisition of Oregon’s Associated Heating & Air...

Jun 11, 2025

Phillips 66 to Speak at the J.P. Morgan 2025 Energy, Power, Renewables & Mining Conference

View all News

Agenda

30
September
PortugalTroia, Portugal
Seabed Security, 30 September - 01 October 2025, Troia, Portugal
Seabed Security | 30 September - 01 October 2025 | Troia, Portugal Defence iQ Announces Inaugural Seabed Security...
23
September
United KingdomLondon, UK
Countering Explosive Threat & Demining conference, September 23 - 24, 2025, London, UK
Countering Explosive Threat & Demining conference | September 23 - 24, 2025 | London, UK The Countering Explosive...
View All Events

SUBSCRIBE

to Epicos.com
Please register in order to have access to personalized daily information on world-wide A&D industry developments and business opportunities.
Subscribe

REGISTER

for Epicos.com Newsletter
Sign up for our free newsletters and receive twice a week news and intelligence regarding the Aerospace & Defence Industry, meticulously selected by our editorial team.
Sign Up
Home
  • SIGN UP FOR NEWSLETTER
  • NEWSLETTER ARCHIVE
  • ADVERTISE WITH US
  • CONTACT US
  • PRIVACY POLICY
  • INFORMATION SECURITY POLICY
© 2025 EPICOS
Made by Wedia